Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hoechst
Frankfurt am Main-Höchst, Hesse, Germanyhoechst.com.pk ↗
- Ownership
- Private
- Employees
- ~100000
- Development stage
- Other
01
Overview
At the time of its merger into Aventis in late '90s, Hoechst had a broad portfolio with major marketed drugs and over sixty projects in development targeting cardiovascular disease, cancer, asthma/allergy, diabetes and CNS disorders. Its legacy includes pioneering work on analgesics and antibiotics.
- Therapeutic areas
- OncologyEndocrinologyImmunologyCardiovascularNeurologyInfectious Diseases
- Modalities
- Small moleculeBiologic
- Industry
- Pharma
02
Partnerships
Rhône-Poulenc S.A.Handok Pharmaceuticals
Beyond the preview
Go deeper on Hoechst.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hoechst.